Preparation and characterization of honokiol nanoparticles

被引：30
作者：
Gou, Ma Ling
Dai, Mei
Li, Xing Yi
Wang, Xian Huo
Gong, Chang Yang
Xie, Yao [2 ]
Wang, Ke
Zhao, Xia [2 ]
Qian, Zhi Yong [1 ]
Wei, Yu Quan
机构：
[1] W China Hosp, W China Med Sch, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, W China Med Sch, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China
来源：
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE | 2008年 / 19卷 / 07期
关键词：
D O I：
10.1007/s10856-007-3361-6
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
In this paper, honokiol nanoparticles were prepared by emulsion solvent evaporation method. The prepared honokiol nanoparticles were characterized by particle size distribution, morphology, zeta potential and crystallography. Results showed that the obtained honokiol nanoparticles at size of 33 nm might be amorphous, and could be well dispersed in water. Due to the great dispersibility in water, the obtained honokiol nanoparticles might have great potential in medical field.
引用
收藏
页码：2605 / 2608
页数：4
相关论文
共 19 条
[1]   Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway [J].
Ahn, Kwang Seok ;
Sethi, Gautam ;
Shishodia, Shishir ;
Sung, Bokyung ;
Arbiser, Jack L. ;
Aggarwal, Bharat B. .
MOLECULAR CANCER RESEARCH, 2006, 4 (09) :621-633
[2]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]   Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo [J].
Bai, XH ;
Cerimele, F ;
Ushio-Fukai, M ;
Waqas, M ;
Campbell, PM ;
Govindarajan, B ;
Der, CJ ;
Battle, T ;
Frank, DA ;
Ye, KQ ;
Murad, E ;
Dubiel, W ;
Soff, G ;
Arbiser, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35501-35507
[4]   The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells [J].
Battle, TE ;
Arbiser, J ;
Frank, DA .
BLOOD, 2005, 106 (02) :690-697
[5]   Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen [J].
Chawla, JS ;
Amiji, MM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :127-138
[6]   Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography [J].
Chen, Lijuan ;
Zhang, Qiang ;
Yang, Guangli ;
Fan, Linyu ;
Tang, James ;
Garrard, Ian ;
Ignatova, Svetlana ;
Fisher, Derek ;
Sutherland, Ian A. .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1142 (02) :115-122
[7]   Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo [J].
Farokhzad, OC ;
Cheng, JJ ;
Teply, BA ;
Sherifi, I ;
Jon, S ;
Kantoff, PW ;
Richie, JP ;
Langer, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6315-6320
[8]   Novel formulations of taxanes: a review. Old wine in a new bottle? [J].
Hennenfent, KL ;
Govindan, R .
ANNALS OF ONCOLOGY, 2006, 17 (05) :735-749
[9]   Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis [J].
Ishitsuka, K ;
Hideshima, T ;
Hamasaki, M ;
Raje, N ;
Kumar, S ;
Hideshima, H ;
Shiraishi, N ;
Yasui, H ;
Roccaro, AM ;
Richardson, P ;
Podar, K ;
Le Gouill, S ;
Chauhan, D ;
Tamura, K ;
Arbiser, J ;
Anderson, KC .
BLOOD, 2005, 106 (05) :1794-1800
[10]   Pluronic® block copolymers for overcoming drug resistance in cancer [J].
Kabanov, AV ;
Batrakova, EV ;
Alakhov, VY .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :759-779
12